Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 6779-6788

  Papadaki, Olympia ^a   Milatos, Stavros ^a   Grammenoudi, Sofia ^a   Mukherjee, Neelanjan ^b   Keene, Jack D ^b   Kontoyiannis, Dimitris L ^a  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; DEATH RECEPTOR; HUR PROTEIN; T LYMPHOCYTE RECEPTOR; CELL CYCLE PROTEIN; CHEMOKINE; ELAV-LIKE PROTEIN 1; MEMBRANE ANTIGEN; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVATION; CELL CYCLE REGULATION; CELL MATURATION; CELL SELECTION; CONTROLLED STUDY; FEMALE; GENE DELETION; GROWTH REGULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; ORGAN SIZE; PERIPHERAL LYMPHOCYTE; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE; THYMOCYTE; THYMUS; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALS; ANTIGENS, SURFACE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CHEMOKINES; MICE; RECEPTORS, DEATH DOMAIN; RNA-BINDING PROTEINS; STEM CELLS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 67449149662     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900377     Document Type: Article

References (50)

1. Bassing, C. H., W. Swat, and F. W. Alt. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109: S45-S55.
2. Starr, T. K., S. C. Jameson, and K. A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21: 139-176.
3. Jin, R., J. Zhang, and W. Chen. 2006. Thymic output: influence factors and molecular mechanism. Cell. Mol. Immunol. 3: 341-350.
4. Takahama, Y. 2006. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6: 127-135.
5. Cheadle, C., J. Fan, Y. S. Cho-Chung, T. Werner, J. Ray, L. Do, M. Gorospe, and K. G. Becker. 2005. Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability. BMC. Genomics. 6: 75-80.
6. Keene, J. D. 2007. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 8: 533-543.
7. Khabar, K. S. 2005. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25: 1-10.
8. Keene, J. D. 1999. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96: 5-7.
9. Gallouzi, I. E., and J. A. Steitz. 2001. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294: 1895-1901.
10. Katsanou, V., O. Papadaki, S. Milatos, P. J. Blackshear, P. Anderson, G. Kollias, and D. L. Kontoyiannis. 2005. HuR as a negative posttranscriptional modulator in inflammation. Mol. Cell. 19: 777-789.
11. Kullmann, M., U. Gopfert, B. Siewe, and L. Hengst. 2002. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev. 16: 3087-3099.
12. Mazan-Mamczarz, K., S. Galban, I. Lopez de Silanes, J. L. Martindale, U. Atasoy, J. D. Keene, and M. Gorospe. 2003. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc. Natl. Acad. Sci. USA 100: 8354-8359.
13. Bhattacharyya, S. N., and W. Filipowicz. 2007. Argonautes and company: sailing against the wind. Cell 128: 1027-1028.
14. Keene, J. D., and S. A. Tenenbaum. 2002. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell. 9: 1161-1167.
15. Gorospe, M., and R. de Cabo. 2008. AsSIRTing the DNA damage response. Trends Cell Biol. 18: 77-83.
16. Kim, H. H., K. Abdelmohsen, A. Lal, R. Pullmann, Jr., X. Yang, S. Galban, S. Srikantan, J. L. Martindale, J. Blethrow, K. M. Shokat, and M. Gorospe. 2008. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 22: 1804-1815.
17. Li, H., S. Park, B. Kilburn, M. A. Jelinek, A. Henschen-Edman, D. W. Aswad, M. R. Stallcup, and I. A. Laird-Offringa. 2002. Lipopolysaccharide- induced methylation of HuR, an mRNA-stabilizing protein, by CARM1: coactivator-associated arginine methyltransferase. J. Biol. Chem. 277: 44623-44630.
18. Mazroui, R., S. Di Marco, E. Clair, C. von Roretz, S. A. Tenenbaum, J. D. Keene, M. Saleh, and I. E. Gallouzi. 2008. Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J. Cell Biol. 180: 113-127.
19. Atasoy, U., J. Watson, D. Patel, and J. D. Keene. 1998. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell Sci. 111: 3145-3156. (Pubitemid 28532425)
20. Casolaro, V., X. Fang, B. Tancowny, J. Fan, F. Wu, S. Srikantan, S. Y. Asaki, U. De Fanis, S. K. Huang, M. Gorospe, U. X. Atasoy, and C. Stellato. 2008. Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR. J. Allergy Clin. Immunol. 121: 853-859.
21. Izquierdo, J. M. 2008. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition. J. Biol. Chem. 283: 19077-19084.
22. Moulton, V. R., V. C. Kyttaris, Y. T. Juang, B. Chowdhury, and G. C. Tsokos. 2008. The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex. J. Biol. Chem. 283: 20037-20044.
23. Sakai, K., Y. Kitagawa, M. Saiki, S. Saiki, and G. Hirose. 2003. Binding of the ELAV-like protein in murine autoimmune T-cells to the nonameric AU-rich element in the 3′ untranslated region of CD154 mRNA. Mol. Immunol. 39: 879-883.
24. Wang, J. G., M. Collinge, V. Ramgolam, O. Ayalon, X. C. Fan, R. Pardi, and J. R. Bender. 2006. LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation. J. Immunol. 176: 2105-2113.
25. Yarovinsky, T. O., N. S. Butler, M. M. Monick, and G. W. Hunninghake. 2006. Early exposure to IL-4 stabilizes IL-4 mRNA in CD4+ T cells via RNA-binding protein HuR. J. Immunol. 177: 4426-4435.
26. Katsanou, V., S. Milatos, A. Yakouvaki, N. Sgantzis, A. Kotsoni, M. Alexiou, V. Harokopos, V. Aidinis, M. Hemberger, and D. Kontoyiannis. 2009. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol. Cell Biol. March 23. E-pub ahead of print.
27. Orban, P. C., D. Chui, and J. D. Marth. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 6861-6865.
28. Mamalaki, C., J. Elliott, T. Norton, N. Yannoutsos, A. R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1993. Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev. Immunol. 3: 159-174.
29. Tarazona, R., O. Williams, D. Moskophidis, L. A. Smyth, Y. Tanaka, M. Murdjeva, A. Wack, C. Mamalaki, and D. Kioussis. 1998. Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice. J. Immunol. 160: 5397-5403. (Pubitemid 28267829)
30. Kisielow, P., H. Bluthmann, U. D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333: 742-746.
31. Staton, T. L., B. Johnston, B. Butcher, and D. J. Campbell. 2004. Murine CD8+ Recent Thymic emigrants are αE and integrin-positive and CC chemokine Ligand 25 Responsive. J. Immunol. 172: 7282-7288.
32. Campbell, J. J., S. Qin, K. B. Bacon, C. R. Mackay, and E. C. Butcher. 1996. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J. Cell Biol. 134: 255-266.
33. Wang, W., H. Furneaux, H. Cheng, M. C. Caldwell, D. Hutter, Y. Liu, N. Holbrook, and M. Gorospe. 2000. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20: 760-769.
34. Kurobe, H., C. Liu, T. Ueno, F. Saito, I. Ohigashi, N. Seach, R. Arakaki, Y. Hayashi, T. Kitagawa, M. Lipp, R. L. Boyd, and Y. Takahama. 2006. CCR7- dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity 24: 165-177.
35. Kishimoto, H., C. D. Surh, and J. Sprent. 1998. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187: 1427-1438.
36. Page, D. M., E. M. Roberts, J. J. Peschon, and S. M. Hedrick. 1998. TNF receptor- deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160: 120-133.
37. Wang, E. C., A. Thern, A. Denzel, J. Kitson, S. N. Farrow, and M. J. Owen. 2001. DR3 regulates negative selection during thymocyte development. Mol. Cell. Biol. 21: 3451-3461.
38. Brennan, C. M., and J. A. Steitz. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58: 266-277.
39. Haks, M. C., P. Krimpenfort, J. H. van den Brakel, and A. M. Kruisbeek. 1999. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 11: 91-101.
40. Aressy, B., B. Bugler, A. Valette, D. Biard, and B. Ducommun. 2008. Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. Cell Cycle 7: 2234-2240.
41. Rother, K., R. Kirschner, K. Sanger, L. Bohlig, J. Mossner, and K. Engeland. 2007. p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene 26: 1949-1953.
42. St Clair, S., and J. J. Manfredi. 2006. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53. Cell Cycle 5: 709-713.
43. Murray-Zmijewski, F., E. A. Slee, and X. Lu. 2008. A complex barcode underlies the heterogeneous response of p53 to stress. Nat. Rev. Mol. Cell Biol. 9: 702-712.
44. Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824-1827.
45. Satyanarayana, A., M. B. Hilton, and P. Kaldis. 2008. p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol. Biol. Cell 19: 65-77.
46. Meisner, N. C., M. Hintersteiner, K. Mueller, R. Bauer, J. M. Seifert, H. U. Naegeli, J. Ottl, L. Oberer, C. Guenat, S. Moss, et al. 2007. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat. Chem. Biol. 3: 508-515.
47. Myers, M. D., T. Sosinowski, L. L. Dragone, C. White, H. Band, H. Gu, and A. Weiss. 2006. Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex. Nat. Immunol. 7: 57.
48. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992.
49. Wen, L., L. Zhuang, X. Luo, and P. Wei. 2003. TL1A-induced NF-κB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J. Biol. Chem. 278: 39251-39258.
50. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360.